Tuesday, February 10, 2026
ADVT 
International

US state's Senate passes bill to allow fireworks during Diwali

Darpan News Desk IANS, 07 Feb, 2023 12:53 PM
  • US state's Senate passes bill to allow fireworks during Diwali

Photo courtesy of IStock. 

New York, Feb 7 (IANS) Lawmakers at the Utah Senate in the US unanimously passed a bill that will make Diwali a state commemorative period, and allow discharge of fireworks during the Indian festival of lights.

Moved by Senator Lincoln Fillmore from South Jordan, the Senate Bill 46 was approved unanimously last week, ABC4 reported.

The bill would designate Diwali as a state commemorative period and will allow the sale and discharge of fireworks during the five days of Diwali, which is usually between late October and early November.

Fillmore said one of his constituents in Herriman reached out to him and gave him the idea for this bill, which needs just one more vote before heading to the House of Representatives.

"I appreciate Utah's Indian community. Their collaborative efforts to organise events to include the neighbouring communities, as well as their efforts to increase education about Hinduism, Jainism and Sikhism, have helped create a better sense of understanding in our state," Senator Fillmore said in a statement.

"This bill recognises others' cultures, contributing to the wonderful tapestry that is Utah."

The bill will be scheduled for a third reading at the Utah Senate in the near future.

Diwali was celebrated in the White House for the first time in 2002, and in 2007, the US government gave official recognition to the festival.

In 2021, the Diwali Day Act was introduced in the US to declare the festival a federal holiday.

This year, Diwali will fall on November 12.

MORE International ARTICLES

COVID vaccine found highly effective in real-world US study

COVID vaccine found highly effective in real-world US study
The two vaccines available since December — Pfizer and Moderna — were 90% effective after two doses, the Centers for Disease Control and Prevention reported Monday. In testing, the vaccines were about 95% effective in preventing COVID-19.

COVID vaccine found highly effective in real-world US study

Reputation of AstraZeneca's COVID vaccine marred by missteps

Reputation of AstraZeneca's COVID vaccine marred by missteps
In Norway, a top official warned on Monday it might not be able to resume its use of the vaccine because so many people were rejecting it.

Reputation of AstraZeneca's COVID vaccine marred by missteps

EXPLAINER: Will you need a 'vaccine passport' to travel?

EXPLAINER: Will you need a 'vaccine passport' to travel?
It is not clear, however, whether any of the passports under development will be accepted broadly around the world, and the result could be confusion among travellers and disappointment for the travel industry.

EXPLAINER: Will you need a 'vaccine passport' to travel?

EXPLAINER: Why Georgia attack spurs fears in Asian Americans

EXPLAINER: Why Georgia attack spurs fears in Asian Americans
As details emerge, many members of the Asian American community see the Georgia killings as a haunting reminder of harassment and assaults that have been occurring from coast to coast.

EXPLAINER: Why Georgia attack spurs fears in Asian Americans

EXPLAINER: Why countries are halting the AstraZeneca shot

EXPLAINER: Why countries are halting the AstraZeneca shot
Norway, Iceland, Bulgaria, Thailand, and Congo soon followed suit. On Saturday, Norwegian authorities reported that four people under age 50 who had gotten the AstraZeneca vaccine had an unusually low number of blood platelets.

EXPLAINER: Why countries are halting the AstraZeneca shot

WHO grants emergency authorization for J&J COVID vaccine

WHO grants emergency authorization for J&J COVID vaccine
In a statement, the U.N. health agency said “the ample data from large clinical trials” shows the J&J vaccine is effective in adult populations. The emergency use listing comes a day after the European Medicines Agency recommended the shot be given the green light across the 27-country European Union.

WHO grants emergency authorization for J&J COVID vaccine